SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • Birner P,Schindl M,Obermair A,Plank C,Breitenecker G,Kowalski H,Oberhuber G. 2000. Lymphatic microvessel density in epithelial ovarian cancer: its impact on prognosis. Anticancer Res 20: 29812985.
  • Currie MJ,Hanrahan V,Gunningham SP,Morrin HR,Frampton C,Han C,Robinson BA,Fox SB. 2004. Expression of vascular endothelial growth factor D is associated with hypoxia inducible factor (HIF-1alpha) and the HIF-1alpha target gene DEC1, but not lymph node metastasis in primary human breast carcinomas. J Clin Pathol 57: 829834.
  • Fox SB,Harris AL. 2004. Histological quantitation of tumour angiogenesis. APMIS 112: 413430.
  • Funaki H,Nishimura G,Harada S,Ninomiya I,Terada I,Fushida S,Tani T,Fujimura T,Kayahara M,Shimizu K,Ohta T,Miwa K. 2003. Expression of vascular endothelial growth factor D is associated with lymph node metastasis in human colorectal carcinoma. Oncology 64: 416422.
  • George ML,Tutton MG,Janssen F,Arnaout A,Abulafi AM,Eccles SA,Swift RI. 2001. VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression. Neoplasia 3: 420427.
  • Jackson DG,Prevo R,Clasper S,Banerji S. 2001. LYVE-1, the lymphatic system and tumor lymphangiogenesis. Trends Immunol 22: 317321.
  • Kaipainen A,Korhoned J,Mustonen T,van Hinsbergh VW,Fang GH,Dumont D,Breitman M,Alitalo K. 1995. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92: 35663570.
  • Katso RM,Manek S,Ganjavi H,Biddolph S,Charnock MF,Bradburn M,Wells M,Ganesan TS. 2000. Overexpression of H-Ryk in epithelial ovarian cancer: prognostic significance of receptor expression. Clin Cancer Res 6: 32713281.
  • Kyzas PA,Denaxa-Kyza D,Ioannidis JP. 2007a. Almost all articles on cancer prognostic markers report statistically significant results. Eur J Cancer 43: 25592579.
  • Kyzas PA,Denaxa-Kyza D,Ioannidis JP. 2007b. Quality of reporting of cancer prognostic marker studies: association with reported prognostic effect. J Natl Cancer Inst 99: 236243.
  • Kyzas PA,Geleff S,Batistatou A,Agnantis NJ,Stefanou D. 2005a. Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma. J Pathol 206: 170177.
  • Kyzas PA,Loizou KT,Ioannidis JP. 2005b. Selective reporting biases in cancer prognostic factor studies. J Natl Cancer Inst 97: 10431055.
  • Liu B,Ma J,Wang X,Su F,Li X,Yang S,Ma W,Zhang Y. 2008. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma. Anat Rec 291: 12271235.
  • Longatto Filho A,Oliveira TG,Pinheiro C,de Carvalho MB,Curioni OA,Mercante AM,Schmitt FC,Gattás GJ. 2007. How useful is the assessment of lymphatic vascular density in oral carcinoma prognosis? World J Surg Oncol 5: 140.
  • McShane LM,Altman DG,Sauerbrei W,Taube SE,Gion M,Clark GM. 2006. Reporting recommendations for tumor marker prognostic studies (REMARK). Breast Cancer Res Threat 100: 229235.
  • Mohammed RA,Green A,El-Shikh S,Paish EC,Ellis IO,Martin SG. 2007. Prognostic significance of vascular endothelial cell growth factors-A,-C and-D in breast cancer and their relationship with angio- and lymphangiogenesis. Br J Cancer 96: 10921100.
  • Mouta Carreira C,Nasser SM,di Tomaso E,Padera TP,Boucher Y,Tomarev SI,Jain RK. 2001. LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. Cancer Res 61: 80798084.
  • Nakamura Y,Yasuoka H,Tsujimoto M,Yang Q,Imabun S,Nakahara M,Nakao K,Nakamura M,Mori I,Kakudo K. 2003. Prognostic significance of vascular endothelial growth factor D in breast carcinoma with long-term follow-up. Clin Cancer Res 9: 716721.
  • Niki T,Iba S,Tokunou M,Yamada T,Matsuno Y,Hirohashi S. 2000. Expression of vascular endothelial growth factor A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. Clin Cancer Res 6: 24312439.
  • O-charoenrat P,Rhys-Evans P,Eccles SA. 2001. Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis. Cancer 92: 556568.
  • Padera TP,Kadambi A,di Tomaso E,Carreira CM,Brown EB,Boucher Y,Choi NC,Mathisen D,Wain J,Mark EJ,Munn LL,Jain RK. 2002. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 296: 18831886.
  • Sangoi AR,McKenney JK,Dadras SS,Longacre TA. 2008. Lymphatic vascular invasion in ovarian serous tumors of low malignant potential with stromal microinvasion: a case control study. Am J Surg Pathol 32: 261268.
  • Schacht V,Dadras SS,Johnson LA,Jackson DG,Hong YK,Detmar M. 2005. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol 166: 913921.
  • Schoppmann SF,Birner P,Stockl J,Kalt R,Ullrich R,Caucig C,Kriehuber E,Nagy K,Alitalo K,Kerjaschki D. 2002. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol 161: 947956.
  • Shimizu K,Kubo H,Yamaguchi K,Kawashima K,Ueda Y,Matsuo K,Awane M,Shimahara Y,Takabayashi A,Yamaoka Y,Satoh S. 2004. Suppression of VEGFR-3 signaling inhibits lymph node metastasis in gastric cancer. Cancer Sci 95: 328333.
  • Sipos B,Klapper W,Kruse ML,Kalthoff H,Kerjaschki D,Klöppel G. 2004. Expression of lymphangiogenic factors and evidence of intratumoral lymphangiogenesis in pancreatic endocrine tumors. Am J Pathol 165: 11871197.
  • Skobe M,Hamberg LM,Hawighorst T,Schirner M,Wolf GL,Alitalo K,Delmar M. 2001. Concurrent induction of lymphangiogenesis, angiogenesis and macrophage recruitment by VEGF-C in melanoma. Am J Pathol 159: 893903.
  • Stacker SA,Achen MG,Jussila L,Baldwin ME,Alitalo K. 2002. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2: 573583.
  • Sundar SS,Zhang H,Brown P,Manek S,Han C,Kaur K,Charnock MF,Jackson D,Ganesan TS. 2006. Role of lymphangiogenesis in epithelial ovarian cancer. Br J Cancer 94: 16501657.
  • Umemoto M,Yokoyama Y,Sato S,Tsuchida S,Al-Mulla F,Saito Y. 2001. Carbonyl reductase as a significant predictor of survival and lymph node metastasis in epithelial ovarian cancer. Br J Cancer 85: 10321036.
  • Von Marschall Z,Scholz A,Stacker SA,Achen MG,Jackson DG,Alves F,Schirner M,Haberey M,Thierauch KH,Wiedenmann B,Rosewicz S. 2005. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer. Int J Oncol 27: 669679.
  • White JD,Hewett PW,Kosuge D,McCulloch T,Enholm BC,Carmichael J,Murray JC. 2002. Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma. Cancer Res 62: 16691675.
  • Williams CS,Leek RD,Robson AM,Banerji S,Prevo R,Harris AL,Jackson DG. 2003. Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer. J Pathol 200: 195206.
  • Wilting J,Papoutsi M,Christ B,Nicolaides KH,von Kaisenberg CS,Borges J,Stark GB,Alitalo K,Tomarev SI,Niemeyer C,Rossler J. 2002. The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues. FASEB J 16: 12711273.
  • Yokoyama Y,Charnock-Jones DS,Licence D,Yanaihara A,Hastings JM,Holland CM,Emoto M,Umemoto M,Sakamoto T,Sato S,Mizunuma H,Smith SK. 2003a. Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma. Br J Cancer 88: 237244.
  • Yokoyama Y,Charnock-Jones DS,Licence D,Yanaihara A,Hastings JM,Holland CM,Emoto M,Sakamoto A,Sakamoto T,Maruyama H,Sato S,Mizunuma H,Smith SK. 2003b. Expression of vascular endothelial growth factor (VEGF)-D and its receptor, VEGF receptor 3, as a prognostic factor in endometrial carcinoma. Clin Cancer Res 9: 13611369.